Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viking Thera (NQ: VKTX ) 64.69 +2.69 (+4.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Viking Thera < Previous 1 2 ... 11 12 13 14 15 16 17 18 Next > Why Is Viking Therapeutics (VKTX) Stock Up 38% Today? March 28, 2023 Viking Therapeutics (VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of weight loss drug VK2735. Via InvestorPlace Why Viking Therapeutics Stock Is Soaring Tuesday March 28, 2023 Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday March 28, 2023 We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! Via InvestorPlace Is Viking Therapeutics a Smart Buy on the Dip? March 27, 2023 The stock recently fell around 25% for reasons that had nothing to do with its lead program. Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's Intraday Session March 21, 2023 Via Benzinga 4 Analysts Have This to Say About Viking Therapeutics March 17, 2023 Via Benzinga 2 Surging Healthcare Stocks That Are Still Worth Buying February 23, 2023 These two NASH drugmakers have a lot of room to run. Via The Motley Fool Viking Therapeutics's Earnings: A Preview February 07, 2023 Via Benzinga Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 21, 2023 Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share. Via Benzinga Analyzing Viking Therapeutics's Short Interest January 03, 2023 Viking Therapeutics's (NASDAQ:VKTX) short percent of float has risen 7.17% since its last report. The company recently reported that it has 1.89 million shares sold short, which is 2.54% of all regular... Via Benzinga 5 Most Expensive Health Care Stocks You Should Worry About January 03, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today December 23, 2022 Via Benzinga Recap: Viking Therapeutics Q3 Earnings October 26, 2022 Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 March 17, 2023 Via Benzinga This Stock That Tripled in 2022 Could Rocket Even Higher in 2023 December 26, 2022 Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results. Via The Motley Fool Why Did Viking Therapeutics Stock Skyrocket December 21, 2022 VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. Via MarketBeat Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session December 19, 2022 Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session December 19, 2022 Via Benzinga Is Elon Musk Stepping Down as Head of Twitter? December 19, 2022 Elon Musk is in the news Monday after the billionaire held a poll asking if he should step down as head of social media company Twitter. Via InvestorPlace Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday December 19, 2022 U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga Why Is Cosmos Health (COSM) Stock Down 58% Today? December 19, 2022 Cosmos Health (COSM) stock is falling hard on Monday after the healthcare company's shares underwent a major rally on Friday! Via InvestorPlace Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning December 19, 2022 Good news can come in different forms. Via The Motley Fool Why Is Viking Therapeutics (VKTX) Stock Up 67% Today? December 19, 2022 Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company. Via InvestorPlace US Stocks Slightly Lower; Nasdaq Down 100 Points December 19, 2022 U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 100 points on Monday. Via Benzinga Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today December 19, 2022 Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session December 19, 2022 Via Benzinga My 3 Top Biotech Stock Picks for 2023 November 22, 2022 Biotech stocks are set to shine in 2023. Via The Motley Fool 12 Health Care Stocks Moving In Wednesday's After-Market Session November 16, 2022 Via Benzinga Earnings Outlook For Viking Therapeutics October 25, 2022 Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Viking... Via Benzinga Earnings Scheduled For October 26, 2022 October 26, 2022 Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion. Via Benzinga < Previous 1 2 ... 11 12 13 14 15 16 17 18 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.